Your browser version may not work well with NCBI's Web applications. More information here...
1: Cell. 2007 Dec 14;131(6):1124-36.
Related Articles, Links
Click here to read Click here to read Click here to read
Comment in:
TAM receptors are pleiotropic inhibitors of the innate immune response.

Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G.

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA 92037, USA.

The activation of Toll-like receptors (TLRs) in dendritic cells (DCs) triggers a rapid inflammatory response to pathogens. However, this response must be tightly regulated because unrestrained TLR signaling generates a chronic inflammatory milieu that often leads to autoimmunity. We have found that the TAM receptor tyrosine kinases-Tyro3, Axl, and Mer-broadly inhibit both TLR and TLR-induced cytokine-receptor cascades. Remarkably, TAM inhibition of inflammation is transduced through an essential stimulator of inflammation-the type I interferon receptor (IFNAR)-and its associated transcription factor STAT1. TLR induction of IFNAR-STAT1 signaling upregulates the TAM system, which in turn usurps the IFNAR-STAT1 cassette to induce the cytokine and TLR suppressors SOCS1 and SOCS3. These results illuminate a self-regulating cycle of inflammation, in which the obligatory, cytokine-dependent activation of TAM signaling hijacks a proinflammatory pathway to provide an intrinsic feedback inhibitor of both TLR- and cytokine-driven immune responses.

Publication Types:
PMID: 18083102 [PubMed - indexed for MEDLINE]